Follow Michael A Robinson Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
As a true tech-sector insider, I do some consulting for Aitonomi, a European startup working on autonomous delivery vehicles guided by artificial intelligence (AI) technology.
In other words: robots.
And thanks to that personal involvement with (and personal interest in) the robotics field, I pay careful attention to the latest technological advances – as well as the mergers and financing deals that make it all possible.
I do this because I understand that mergers are one way for a startup with promising technologies to get access to the cash, know-how, and other resources needed to grow – not to mention that these deals allow the original investors to reap the benefits of their efforts.
And funding deals not only give startups the capital "fuel" they need for growth, but they also serve as a "stamp of approval" signaling other financiers that it's okay to invest.
Let's look at the latest deals. I'll not only tell you what they mean, but I'll also show you a great way to cash in on the powerful robotics trend – starting right now.
It's one of the greatest wealth opportunities I see today…
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.